FDA Import Refusal AEK-9383848-8/60003/1 — Bajaj Formulations
The FDA refused shipment AEK-9383848-8/60003/1 from Bajaj Formulations (India) on Feb 20, 2026. The refused product falls under Drugs and Biologics — TELMISARTAN (ANTI-HYPERTENSIVE - PART II). Cited charges: 118,75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Feb 20, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62ODY09 TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
- Charges
- 118,75